| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/15/2009 | CA2692802A1 Tnf superfamily collectin fusion proteins |
| 01/15/2009 | CA2692682A1 Methods and compositions useful in the treatment of mucositis |
| 01/15/2009 | CA2692637A1 Treatment and diagnostic methods for fibrosis related disorders |
| 01/15/2009 | CA2692453A1 Methods and compositions for inactivating alpha 1,6 fucosyltransferase (fut8) gene expression |
| 01/15/2009 | CA2692037A1 Il-23 receptor antagonists and uses thereof |
| 01/15/2009 | CA2691898A1 Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-msh) and atrial natriuretic protein (anp) and uses in hypertension and acute kidney injury |
| 01/15/2009 | CA2691883A1 Method for the production of an aqueous glucose solution |
| 01/15/2009 | CA2691692A1 Prevention of disulfide bond reduction during recombinant production of polypeptides |
| 01/15/2009 | CA2690629A1 Multipotent/pluripotent cells and methods |
| 01/15/2009 | CA2688548A1 Enhancement of glycoprotein incorporation into virus-like particles |
| 01/14/2009 | EP2014776A2 Diagnosis of diseases associated with DNA transcription |
| 01/14/2009 | EP2014772A2 Method for the diagnosis and prognosis of cancer |
| 01/14/2009 | EP2014770A2 WNT-1 Iinduced secreted polypeptide WISP-2 |
| 01/14/2009 | EP2014766A1 Method for differentiation induction of myocardial cell from pluripotent stem cell |
| 01/14/2009 | EP2014679A1 KDR peptides and vaccines comprising the same |
| 01/14/2009 | EP2014678A2 KDR peptides and vaccines comprising the same |
| 01/14/2009 | EP2014677A1 A-33 related antigens and their pharmacological uses |
| 01/14/2009 | EP2014676A1 Hgf precursor protein mutant and activated form thereof |
| 01/14/2009 | EP2014675A1 Compositions and methods for the treatment of immune related diseases |
| 01/14/2009 | EP2014674A1 Protein-protein interactions in human immunodeficiency virus |
| 01/14/2009 | EP2014673A1 Tumour-associated peptides which bind to MHC molecules |
| 01/14/2009 | EP2014318A2 Method for producing demineralized bone matrix easily releasing bone morphogenetic protein and method for extracting bone morphogenetic protein using demineralized bone matrix by irradiation |
| 01/14/2009 | EP2014310A2 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
| 01/14/2009 | EP2014300A1 Cancer vaccine comprising a cancer antigen based on the product of a tumor suppressor gene WT1 and a cationic liposome |
| 01/14/2009 | EP2014298A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 01/14/2009 | EP2014297A1 Control of intracellular target molecule by ip3 receptor-binding protein |
| 01/14/2009 | EP2014180A1 Composition useful for the reduction of the cardivascular risk and foods that contain it |
| 01/14/2009 | EP2013350A1 Transgenic plants and methods for controlling bolting in sugar beet |
| 01/14/2009 | EP2013342A1 Auto- inducible sodium phosphate symporter promoter from pichia pastoris and method for producing recombinant protein using it |
| 01/14/2009 | EP2013340A2 Method for cloning and expression of nrui restriction endonuclease |
| 01/14/2009 | EP2013234A2 Peptide compound with biological activity, its preparation and its application |
| 01/14/2009 | EP2013233A2 Use of tm-601 for the diagnosis and treatment of tumors |
| 01/14/2009 | EP2013232A2 Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation |
| 01/14/2009 | EP2013230A2 Hpv-16-based papillomavirus vaccine |
| 01/14/2009 | EP2013229A2 Hpv-18-based papillomavirus vaccine |
| 01/14/2009 | EP2013228A1 Methods of inducing apoptosis of cancerous cells using apoptin derivatives |
| 01/14/2009 | EP2013227A1 Hiv-1 immunogenic compositions |
| 01/14/2009 | EP2012829A2 Method for producing viral vaccine and therapeutic peptide antigens |
| 01/14/2009 | EP2012818A1 Hydrolysate of avian cartilage, process of preparation and uses thereof |
| 01/14/2009 | EP1761638A4 Methods and agents for screening for compounds capable of modulating vegf expression |
| 01/14/2009 | EP1751289B1 Tc-83-derived alphavirus vectors, particles and methods |
| 01/14/2009 | EP1730172A4 Methods and compositions for the treatment of gastrointestinal disorders |
| 01/14/2009 | EP1704239B1 Integrase fusion proteins and their use with integrating gene therapy |
| 01/14/2009 | EP1687636B1 Rapid determination of different forms of hepatocyte growth factor (hgf) in the body fluids |
| 01/14/2009 | EP1659918B1 Antibodies directed to parathyroid hormone (pth) and uses thereof |
| 01/14/2009 | EP1653844A4 Prion-specific peptide reagents |
| 01/14/2009 | EP1616953B1 Method of detecting beta 3 adrenaline receptor mutant gene and nucleic acid probe and kit therefor |
| 01/14/2009 | EP1609858B1 Method for detecting substrates or inhibitors for branched neutral amino acid transporters |
| 01/14/2009 | EP1590447A4 Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots |
| 01/14/2009 | EP1572967B1 Il-1 receptor based antagonists and methods of making and using |
| 01/14/2009 | EP1487486B1 Imidazoquinolineamines as adjuvants in hiv dna vaccination |
| 01/14/2009 | EP1485412B1 Repressor of skeletal muscle differentiation, nucleic acids coding therefor and the use thereof in diagnosis and therapy |
| 01/14/2009 | EP1476202B1 Cross-linked bioactive hydrogel matrices |
| 01/14/2009 | EP1377305B1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of an-giogenesis |
| 01/14/2009 | EP1360314B1 Chemically defined medium for cultured mammalian cells |
| 01/14/2009 | EP1341810B1 Secreted chlamydia polypeptides and method for identifying such polypeptides by their secretion by a type iii secretion pathway of a gram-negative bacteria. |
| 01/14/2009 | EP1331270B1 Novel recombinant feline herpesvirus 1 and polyvalent vaccine with the use of the same |
| 01/14/2009 | EP1210724B1 Method of determining etch endpoint using principal components analysis of optical emission spectra |
| 01/14/2009 | EP1187918B2 Tek antagonists |
| 01/14/2009 | EP1130029B1 Protein amsh and cdna thereof |
| 01/14/2009 | EP1115877B1 Polynucleotide constructs and uses thereof |
| 01/14/2009 | EP1025218B1 Libraries of human antibody polypetides |
| 01/14/2009 | EP1002085B1 Methods and means for control of flowering in plants |
| 01/14/2009 | EP0948614B1 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
| 01/14/2009 | EP0948539B1 Peptides and compounds that bind to a receptor |
| 01/14/2009 | EP0724594B1 Regulation of transcription factor, nf-il6/lap |
| 01/14/2009 | CN101346395A Anti-IL-6 antibodies preventing the binding of IL-6 complexed with il-6Ralpha to GP130 |
| 01/14/2009 | CN101343652A Mushroom ferment crude protein with antineoplastic activity, extracting method and formulation |
| 01/14/2009 | CN101343651A Mushroom ferment pure protein with antineoplastic activity, extracting method and formulation |
| 01/14/2009 | CN101343632A Chicken silk feather character gene and uses thereof |
| 01/14/2009 | CN101343318A Peptide-polymer conjugates |
| 01/14/2009 | CN101343317A Brain peptide, preparation and uses thereof |
| 01/14/2009 | CN101343316A Kalium ion transport associated protein system, encoding gene cluster and application thereof |
| 01/14/2009 | CN101343315A Shorten human papilloma virus 6 type L1 protein |
| 01/14/2009 | CN101343314A Shorten human papilloma virus II type L1 protein |
| 01/14/2009 | CN101342368A Antigenized antibody vaccine for foot-and-mouth disease |
| 01/14/2009 | CN101342365A Use of novel glucagon-like peptide-1 (GLP-1) analogue |
| 01/14/2009 | CN101341886A Enhancement of growth in plants |
| 01/14/2009 | CN100451127C Peptides with anti-hypertensive properties |
| 01/14/2009 | CN100451121C Gene for controlling rice ear sprouting period and its uses |
| 01/14/2009 | CN100451117C Dehiscence gene and methods for regulating dehiscence |
| 01/14/2009 | CN100451116C Human tissue factor pathway inhibitory factor mutation gene mTFPI, recombination carrier including the same and host cell thereof |
| 01/14/2009 | CN100451115C Modulators of intracellular inflamation, cell death and cell survival pathways containing a card and kinase domain |
| 01/14/2009 | CN100451108C L-lysine-producing corynebacteria and process for the preparation of L-lysine |
| 01/14/2009 | CN100451104C L-lysine producing coryneform bacteria and methods for the production of L-lysine |
| 01/14/2009 | CN100451034C Pig gamma interferon and encoding genes and use thereof |
| 01/14/2009 | CN100451033C Gene for inhibiting human transcription factor AP-1, its encoding polypeptide and uses |
| 01/14/2009 | CN100451032C Oyster low molecular active peptide and its preparation method and application in the preparation of anticancer medicine |
| 01/14/2009 | CN100450551C Recombinated adeno-associated virus genes vaccine for prevention and cure of Alzheimer disease and use thereof |
| 01/13/2009 | US7477177 A-D converter, A-D convert method, and A-D convert program |
| 01/13/2009 | US7476732 Nucleic acid encoding α chain of human IL-11 receptor |
| 01/13/2009 | US7476728 Flea GABA receptor subunit nucleic acid molecules |
| 01/13/2009 | US7476726 employed for large scale recovery and purification; centrifugation of the broth from fermentation steps in recombinant production of endostatin protein is avoided, thereby preventing unwanted potential cellular lysis and potential contamination |
| 01/13/2009 | US7476723 Nucleotide sequences coding membrane protein ; antiproliferative agents; anticancer agents; antiinflammatory agents |
| 01/13/2009 | US7476722 Chromatography separation using apatite; protein being purified can comprise at least one constant antibody immunoglobulin domain |
| 01/13/2009 | US7476721 Modified cytokines for use in cancer therapy |
| 01/13/2009 | US7476720 Rat neurotrophic factor receptor, GFR α-4 |
| 01/13/2009 | US7476719 Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof |
| 01/13/2009 | US7476651 Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis |
| 01/13/2009 | US7476649 Antiproliferative and antiviral proteins and peptides |